06 April 2017
Bowel Cancer Awareness Month runs throughout April.
Some of the principal treatments carried out by Mr Howard Marsh at Spire include:
I qualified in 1993 from Bristol University Medical School. I went on to do my Basic Surgical Training in London and Higher Surgical Training in Oxford, gaining my MD in Genetic Polymorphisms in Bladder Cancer Angiogenesis in 2005. I passed FRCS (Urol) in 2007. I took up post as Consultant Urologist at Medway Maritime Hospital in December 2008. Whilst I am part of the urology on-call rota, I am experienced in and enjoys all aspects of general urology.
My special interests are minimally invasive treatments of the upper tract and all aspects of urological stone disease. I have been instrumental in setting up a fully comprehensive Stone Centre together with Mr John Palmer and Mr S Sriprasad. All cases are discussed and managed by the team and techniques include rigid and flexible ureteroscopy and laser stone fragmentation, percutaneous nephrolithotomy, extracorporeal lithotripsy and laparoscopy. I have strong links with Darent Valley Hospital where I operate every fortnight.
I am currently playing a lead role in The Productive Operating Theatre programme at Medway, which is committed to improving patient safety and working practice within theatres. I am also involved in implementing an Enhanced Recovery Programme whereby patient pre and post-operative care is streamlined to improve patient outcome and experience. I have recently published a series of articles relating to medico-legal issues in the British Journal of Urology.
|Telephone||01634 662822 / 845|
|Private secretary||Mrs Gillian Rolfe|
|Private secretary telephone||01622 538119 / 538120|
|Private secretary fax||01634 560111|
|Private secretary firstname.lastname@example.org|
British Association of Urological Surgeons.
European Association of Urology.
Royal Society of Medicine.
British Medical Association.
Royal College of Surgeons.
Medway Maritime Hospital.Back to top
I am married to a local GP and has three children.Back to top
09 March 2017
Ovarian cancer is often called ‘the silent killer’ but early detection can lead to successful treatment for sufferers.